Table 1.
Clinical and MRI variables of patients in activity period and remission at 1 year
| Characteristics, n = 76 | Baseline | 1 year | P value |
|---|---|---|---|
| Clinical variables | |||
| TJC28 | 4.2 ± 3.1 | 0 | < 0.001 |
| SJC28 | 3.5 ± 2.6 | 0 | < 0.001 |
| DAS28 | 4.2 ± 1.3 | 1.9 ± 0.5 | < 0.001 |
| ESR | 32.5 ± 12.6 | 14.6 ± 6.1 | < 0.001 |
| CRP | 15.8 ± 5.4 | 6.3 ± 3.2 | < 0.001 |
| RF | 59/76 (77.6%) | 53/76 (69.7%) | 0.27 |
| CCP | 63/76 (82.9%) | 59/76 (77.6%) | 0.42 |
| MRI variables | |||
| Synovitis | 6.1 ± 3.8 | 4.0 ± 2.4 | < 0.001 |
| BME | 5.9 ± 4.6 | 2.9 ± 2.2 | < 0.001 |
| Tenosynovitis | 4.9 ± 3.4 | 1.6 ± 1.1 | < 0.001 |
| Bone erosion | 6.4 ± 5.6 | 7.1 ± 6.5 | 0.31 |
ESR erythrocyte sedimentation rate, DAS disease activity score, CRP the C-reactive protein, RF rheumatoid Factor, ACPA anticyclic citrullinated peptide antibody, TJCs tender joints, SJCs swollen joints, BME bone marrow edema